At least 13 reported missing as torrential rain hits Japan’s Kyushu

This aerial view shows the Kuma River flooded with heavy rain in Yatsushiro, Kumamoto prefecture, southwestern Japan, on Saturday. (Kyodo News via AP)
Short Url
Updated 04 July 2020

At least 13 reported missing as torrential rain hits Japan’s Kyushu

  • Highest warning for floods and landslides triggered by the rain “never seen” before in the region

TOKYO: Unprecedented torrential rains pounded Japan’s southern island of Kyushu, where at least 13 people have gone missing as weather officials warned against the threat of floods and landslides, public broadcaster NHK said on Saturday.
Television broadcast images of houses and cars submerged in muddy waters in the prefecture of Kumamoto, where NHK said the flooding Kuma River was cutting off homes and had washed away a bridge.
Japan’s Meteorological Agency issued its highest grade of warning for floods and landslides triggered by the rain “never seen” before in the region, the broadcaster added.
More than 100 appeals for rescue flowed in to local authorities but they could not respond to all immediately, NHK said.

 

 

 


US to pay over $1 bn for 100 mln doses of J&J’s potential COVID-19 vaccine

Updated 05 August 2020

US to pay over $1 bn for 100 mln doses of J&J’s potential COVID-19 vaccine

  • The latest contract equates to roughly $10 per vaccine dose produced by J&J
  • This is J&J’s first deal to supply its investigational vaccine to a country

WASHINGTON: The United States government will pay Johnson & Johnson over $1 billion for 100 million doses of its potential coronavirus vaccine, its latest such arrangement as the race to tame the pandemic intensifies, the drugmaker said on Wednesday.
It said it would deliver the vaccine to the Biomedical Advanced Research and Development Authority (BARDA) on a not-for-profit basis to be used after approval or emergency use authorization by the US Food and Drug Administration (FDA).
J&J has already received $1 billion in funding from the US government — BARDA agreed in March to provide that money for the company to build manufacturing capacity for more than 1 billion doses of the experimental vaccine.
The latest contract equates to roughly $10 per vaccine dose produced by J&J. Including the first $1 billion deal with the USgovernment, the price would be slightly higher than the $19.50 per dose that the United States is paying for the vaccine being developed by Pfizer Inc. and German biotech BioNTech SE.
The US government may also purchase an additional 200 million doses under a subsequent agreement. J&J did not disclose that deal’s value.
J&J plans to study a one- or two-dose regimen of the vaccine in parallel later this year. A single-shot regimen could allow more people to be vaccinated with the same number of doses and would sidestep issues around getting people to come back for their second dose.
This is J&J’s first deal to supply its investigational vaccine to a country. Talks are underway with the European Union, but no deal has yet been reached.
J&J’s investigational vaccine is currently being tested on healthy volunteers in the United States and Belgium in an early-stage study.
There are currently no approved vaccines for COVID-19. More than 20 are in clinical trials.